health and life sciences

Slides:



Advertisements
Similar presentations
Professor Dave Delpy Chief Executive of Engineering and Physical Sciences Research Council Research Councils UK Impact Champion Competition vs. Collaboration:
Advertisements

Driving Innovation Technology and Innovation Centres Mike Oldham Programme Manager Technology Strategy Board UKSPA Nottingham – 19 th May 2011.
West Midlands Academic Health Science Network July 24 th 2013.
West Midlands Academic Health Science Network Mental Health Clinical Priority Event October 10 th, 2013 Peter Lewis Medical Director, Birmingham and Solihull.
Cleantech Incubation Europe Working Summit   Peterborough, UK 4 June 2013 Lynne McGregor Lead Technologist High Value Manufacturing Technology Strategy.
European Framework Programme for Business FP7 UK Technology Strategy Board Driving Innovation FP7UK NMP and PPP 2011 Calls Alastair McGibbon National Contact.
Making Innovation Affordable Jo Derbyshire European Commercial Manager
Industry Growth Centres Initiative National Roadshow Department of Industry.
UK Economic Context & Growth Opportunities - The Structural & Investment Funds challenge - 17 May 2013.
Industry Growth Centres Initiative National Roadshow Department of Industry.
ESIF Priority Areas and Detailed Design Workshop Tuesday 2 December 2014 Sheffield Hallam University The Sheffield City Region and Innovation Yasmin Knight,
Mark Glover 12 th January 2011 Biomedical Catalyst and Other Current Funding Calls 24 th June 2014 – Cardiff Neil Morgan, Medtech Specialist.
CUHP Cambridge University Health Partners (CUHP) unites a world-leading University and three high- performing NHS Foundation Trusts centred on the Cambridge.
0 Scottish Enterprise is Scotland’s Enterprise, Innovation and Investment agency. We are driven by Scotland's key industries to help build a world class.
Driving Innovation Concept to Commercialisation A strategy for business innovation, Zahid Latif Head of Healthcare Mark Glover 12 th January.
Australia’s International Business Events Sector The Economic and Strategic Value Proposition Conference on the Value of Meetings, JMIC 2015.
1 The UK Opportunity: what is experimental medicine? UNLOCK YOUR GLOBAL BUSINESS POTENTIAL Pre- clinical develop- ment Phase I Phase II Phase III Product.
The NIH Roadmap for Medical Research
1 Presentation title - edit in the Master slide 1 Current Investment Opportunities Professor Rory Shaw, Medical Director, Healthcare UK, UKTI.
Mark Glover 12 th January 2011 Driving Innovation The Technology Strategy Board September 2012 Tim Just (delivered by Paul Febvre)
Driving Innovation Concept to Commercialisation A strategy for business innovation, David Bott Director of Innovation Programmes Mark Glover.
Director, DG RTD, Directorate International Cooperation
Barriers to innovation – and solutions The Collaboration Conundrum Colette Goldrick, Director ABPI Northern Ireland.
Emily Nott Relationship Manager - Research Councils IT Community Summit 3 April 2008 Technology Strategy Board V
European Structural and Investment Funding (ESIF) AHSN ESIF/ LEP knowledge sharing webinar 24 February 2016.
NHS Confederation Annual Conference 4 June Matching Health with Growth – the UHB Story.
Driving Innovation Making the UK a global leader in innovation Merlin Goldman 8 September 2011.
Driving Innovation Concept to Commercialisation A strategy for business innovation, David Bott Director of Innovation Programmes Mark Glover.
Roadmap Economic Impact & Funding Opportunities Dr Stephen Hillier
Independent Living Innovation Platform 04/03/15 Hazel Harper ILIP Programme Manager Innovate UK.
Presentation to Low Carbon Vehicle Event – Millbrook 2013 Intelligent Mobility and Low Carbon Vehicles Daniel Ruiz September 2013.
The opportunities and challenges of sharing genomics data with the pharmaceutical industry Shahid Hanif, Head of Health Data & Outcomes, ABPI DNA digest.
Driving Innovation Technology Strategy Board The UK’s agency for business innovation –Business benefit –Economic growth –Quality of life.
Driving Innovation Competition Scope and Background Merlin Goldman 27 September 2011.
Driving Innovation V Driving Innovation V Invitation to further collaboration Dr Anne Miller Environmental Sustainability KTN.
HUCBMS Annual Conference 2016 Enabling Innovation to Improve the International Competitiveness of the Midlands Engine Michael Carr PVC Employer and Economic.
Launch Event 13 October 2016 Motorpoint Arena, Cardiff.
Martin Tugwell 17tNovember 2016
Supporting R&D in the UK
The UK’s agri-tech sector strategy
NIHR Invention for Innovation (i4i)
Innovation in SW Agenda What is a LEP Our priorities
Heat Energy Theme Workgroup, ETP
Dr Chris Parker CBE Managing Director WMAHSN
Creating a culture of innovation
UK Agri-Tech Innovation Ian Cox Lead Technologist Agri-Tech Centres
The Knowledge Transfer Network (KTN) and UK Agri-Tech
FP7 – ICT Theme a motor for growth, competiveness and social inclusion
Welcome.
Luisa PRISTA DG Research and Innovation
Finland, a Global Testbed for Personalized Cancer Research?
The Industrial Strategy Challenge Fund & the Focus on Life Sciences
Global Challenge Research Fund (and other things)
UK Industrial Strategy: Place is the new black
Infrastructure Investment Strategy
Introduction to the Academic Health Science Network (AHSN NENC)
The route to Government funding
Radisson Blu, London Stansted
Clean Growth Grand Challenge Industrial Clusters mission We will establish the world’s first net-zero carbon industrial cluster by 2040 and at least.
Experimental Medicine Challenge Grants Round 3
Transforming Society through Ground- breaking Research
This is Wales – Prioritising UK Research and Innovation Funding
UKRI: A unified voice for research and innovation
Key Cities and the Industrial Strategy
Head of Reserach & Enterprise Partnerships, University of Leicester
Local Industrial Strategies
Industrial Strategy – our ambitions
Industrial Strategy Grand Challenges
Healthy Ageing Challenge
Energy Catalyst Round 7 Iain Wheeler Bid Manager 24th July 2019
Presentation transcript:

health and life sciences Driving innovation in health and life sciences Dr Ian Campbell Director, Health and Life Sciences @IanWCampbell 15 minutes including questions Ask who has heard of Innovate UK Ask who has had Innovate UK funding

We can’t stop thinking about the future Innovate UK – the UK’s innovation agency We work with people, companies and partner organisations to find and drive the science and technology innovations that will grow the UK economy - delivering productivity, new jobs and exports. Our aim at Innovate UK is to keep the UK globally competitive in the race for future prosperity. We can’t stop thinking about the future Innovate UK’s mission – growth, productivity, jobs, exports.

11,000 projects 70,000 jobs created And a return on investment of up to £7.30 for every £1 invested. Cross cutting nature within Innovate UK From health and life sciences themes Across into high value manufacturing themes.

Sectors approach to supporting businesses Emerging and Enabling Health and Life Sciences Infrastructure Systems Manufacturing Materials Open Programme We have simplified our offering into four sectors, of which health and life sciences is one, and an open programme which funds the best innovation regardless of the sector it comes from. Each of these sectors has broad-themed competitions. You can find out latest range of competitions on our website – innovateuk.org Our competitions schedule includes programmes run with partners – more details on our webpage

Economic / societal challenges Health and Life Sciences Economic / societal challenges Market potential Mechanisms Global population growing by 2bn to 9.7bn by 2050 50% more food needed by 2030 Healthcare costs rising > GDP Prevalence of chronic illness and diet related disease increasing Sector Market Year Pharmaceuticals $1.7tn 2025 Healthcare IT $202bn Medical technology $583bn Food (retail) $4.0tn 2016 Agriculture $2.4tn CR&D competitions Catapults and Agri Centres Biomedical Catalyst AgriTech Catalyst SBRI Knowledge Transfer Partnerships Priority themes Partnerships Place BEIS, DH, OLS, DIT, Defra, DfID Devolved Administrations Research Councils ABPI, BioIndustry Association British In Vitro Diagnostics Association Agricultural Levy Boards Precision Medicine Medicines Discovery Advanced Therapies Agricultural Productivity Food Quality Health and Life Sciences supports businesses across UK - map shows locations of sector funded project partners

Partnerships in health and life sciences Innovate UK does not work alone These are the many partners and co-funders that my team work with on a daily basis to deliver our programmes supporting UK businesses. From working together with the research councils to drive the best science through to commericalisation To working with government departments and business support organisations in the devolved nations to deliver some of the examples I will talk about today.

Supporting health and life science businesses around the UK Heat map showing locations of Innovate UK project partners in the health and life science sector This heat map shows the locations of project partners – researchers and businesses – that we have supported in the health and life science area. There are concentrations in the big cities where businesses, universities and hospitals are based. But there are also hot spots in rural areas with an agriculture focus. Key message here – keep applying and seek support in raising the quality of applications to help with getting above the funding threshold.

Innovate UK in the East of England Total Innovate UK grant and unique applicants 2010/11 – 2016/17 Over £231 million to 2000 business innovation projects* GCGP £159m 1,228 South East £71m 580 Hertfordshire £44m 436 New Anglia £18m 286 *LEP areas overlap, affects totals. Not the only measure of innovation activity All Innovate UK grants inc. large projects 2009 - Aug 2016

Innovate UK in the East of England Beattie Passive Scottow Enterprise Zone Processors & Growers Research Organisation Peterborough Cambridge Nanotherm Haverhill Sphere Fluidics Babraham Research Campus, Cambridge Revolve Technologies Brentwood Puridify Stevenage BioScience Catalyst All Innovate UK grants inc. large projects 2009 - Aug 2016

The government’s Industrial Strategy sets out to do just this. Investing in science, research & innovation Upgrading infrastructure Improving procurement Delivering affordable energy & clean growth Driving growth across the whole country Developing skills Supporting businesses to start & grow Encouraging trade & inward investment Cultivating world-leading sectors Creating the right local institutions Innovation doesn't just happen – it takes strategic coordination between business, government, researchers in academia and private sector investors. The government’s Industrial Strategy sets out to do just this. Innovation weaves throughout the strategy It is clearly a big focus through pillar number 1 – science, research and innovation But also through skills, growth across the whole country, supporting businesses to start and grow, trade and inward investment, creating the right local institutions (like our Catapult network) and making the UK the best place in the world to innovate in different industries Areas relevant to AMR – most of them!

Industrial Strategy Challenge Fund Investing in science, research and innovation We must become a more innovative economy and do more to commercialise our world leading science base to drive growth across the UK Industrial Strategy Challenge Fund Industry-led and powered by multi-disciplinary research and business academic collaboration Develop UK industries that are fit for the future, driving progress in technologies where the UK can become a world-leader in research and commercialisation Pillar 1 of the Industrial Strategy has seen a lot of interest since the Prime Minister’s announcement of the new Industrial Strategy Challenge Fund The Chancellor announced £4.7 billion for this parliament for this Fund, reaching £2 billion a year in funding. It will run across Innovate UK and across the Research Councils - through the new UK Research and Innovation structure set to launch in a year’s time. This really is the future of innovation – industry-led and powered by multi-disciplinary research and business academic collaboration. The Fund will bridge research, translation and business. And it will be challenge-focused – bringing sectors together to focus on the big problems that we can better solve by working together, combining science and business expertise.

Industrial Strategy Challenge Fund Medicines manufacturing technologies Robots for a safer world 6 challenges have been announced within the Industrial Strategy Challenge Fund so far – shown here on this slide. Accelerating patient access to new drugs and treatments through developing brand new medicine manufacturing technologies Developing cutting-edge artificial intelligence and robotics systems that will operate in extreme and hazardous environments Development, design and manufacture of batteries that will power the next generation of electric vehicles Developing the next generation of AI and control systems need to ensure the UK is at the forefront of the driverless cars revolution Developing the next generation of affordable light-weight composite materials for aerospace, automotive and other advanced manufacturing sectors New satellite test facility supporting new launch technologies and the manufacturing and testing capabilities that will allow the UK to construct future satellites and deliver payloads into orbit And to hit the ground running, we have funded 35 projects with £10 million in a first wave – making the most of high quality projects that we haven’t been able to fund from our existing budget. Most relevant challenge so far is medicines manufacturing technology – say here what you can within purdah… Batteries for clean and flexible energy storage Self-driving vehicles Manufacturing and materials of the future Satellites and space technology

£197m Medicines manufacturing technologies over 4 years The medicines manufacturing challenge seeks to develop technologies for the manufacture of medicines that will speed up patient access to new drugs and treatments. This will build on the exporting strengths of the UK’s biopharmaceutical sector. Delivering new medicines to patients takes time, and we need to speed this up. Here we are talking about traditional medicines but also biologics, cell and gene therapies, and vaccines. £197 million has been announced for this challenge across the next 4 years. First stages are [Ian to add verbal comments he is comfortable saying]. Developing first-of-a-kind technologies for the manufacture of medicines that will speed up patient access to new drugs and treatments, building on the exporting strengths of the UK’s biopharmaceutical sector

ISCF: Digital Health Technology Catalyst AIM: to speed up the development of new digital solutions to healthcare challenges and grow the industry. Projects must focus on the feasibility or development of digital health or digitally-enabled medical technologies. These must have the potential to achieve one or more of the following: improve patient outcomes transform healthcare delivery enable more efficient delivery of healthcare Technologies may be designed to be used in both clinical/ non-clinical everyday settings. Digital health is evolving at a rapid pace and this is having a profound impact on healthcare delivery. Digital health uses data and technology to: - improve patient outcomes - improve access to healthcare - make more targeted and personalised health interventions - transform service delivery - deliver new treatments and translational medicine As this is the first DHTC call, we have deliberately gone with a broad scope.

Digital Health Technology Catalyst Feasibility Industrial Research and Experimental Development Total Project Costs £50,000 to £75,000 £500,000 to £1m Project Duration Up to one year 1 to 3 years Project Start Date By February 1st 2018 Project Type Single SME or collaboration Collaboration Project Lead UK based SME Application Process Single written Dates & Timelines Competition opens: 31st July ‘17 Registration by: 4th Oct ‘17 Application by: 11th Oct ’17

Precision medicine: impacting through innovative technology Precision Medicine Competition: Impacting through Innovative technology Innovate UK will invest up to £6 million in innovation projects to support the development of precision medicine (PM) technologies. Feasibility – for analysis and evaluation of a concept’s potential, identify the requirements and resources needed to develop the technology, and establish the prospects of success. Research  and development - for research and development applications, to develop and trial precision medicine technologies.  Projects must look to advance precision medicine by guiding decision-making using one of the following approaches: Developing tools to better integrate informatics and data. Establishing precision medicine clinical trials. Developing rapid diagnostics to inform better treatment decisions.

The UK’s innovation agency Precision Medicine Competition: Impacting through Innovative technology Feasibility projects : can last up to 12 months and have total project costs of up to £100,000. can be from a single SME or an SME working with other businesses or research organisations collaborative projects led by an SME Collaborative research and development projects : can last up to 24 months and have total project costs of between £1 million to £2 million. be collaborative and include at least 2 grant-claiming organisations be led by a UK based company or RTO of any size In this competition we are not funding projects that:  do not inform treatment decisions focus on drug discovery, biomarker discover, diagnostic tests for treatments that are still in development, unless justified as a parallel development, such as a companion diagnostic

The UK’s innovation agency Precision Medicine Competition: Impacting through Innovative technology You must explain clearly how your proposed technology will advance precision medicine. All proposals must offer innovative precision medicine technologies that improve the decision-making process for patient treatment selection Competition dates: Opens: 11th September 2017 Application Deadline: 25th October 2017 Applicants notified: 1st February 2018

We can’t stop thinking about the future Supporting UK businesses, researchers and clinicians across health and life sciences We can’t stop thinking about the future